POLA PEMBERIAN AMOKSISILIN PADA BEBERAPA MORBIDITAS LAYANAN

Sri Setiatjahjati (1) , Sahnaz Sahnaz (2) , Rina Rina (3) , eydina eydina (4) , Rismayanti Rismayanti (5)
(1) Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari,
(2) Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari,
(3) Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari,
(4) Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari,
(5) Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari
https://doi.org/10.53675/jsfar.v11i2.1203
crossmark

##plugins.themes.bootstrap3.article.sidebar##

Terbitan
Vol 11 No 2 (2023): SABDARIFFARMA
Telah diserahkan
2024-03-22
Diterbitkan
2024-03-22
PDF (Inggris)

Abstrak

Latar Belakang: Kemampuan antibiotik tidak perlu diragukan lagi, akan tetapi penggunaannya yang tidak rasional akan segera diikuti dengan munculnya kuman kebal antibiotik. Penelitian ini bertujuan untuk menggambarkan tren  pada pola resep obat antibiotik amoksisillin dan untuk menilai potensi resistensi antibiotik pada morbiditas yang berbeda. Metode: Penelitian deskriptif non eksperimental berdasarkan data Retrospektif  dengan sampel pasien yang mendapat terapi antibiotik amoksisilin pada bulan Januari-Maret 2019. Data yang dianalisis adalah gambaran rasionalitas penggunaan amoksisillin meliputi tepat obat, tepat dosis, tepat lama pemberian.  Data penelitian atas ijin  dengan melihat rekam medis dan resep pasien yang mendapat terapi antibiotik amoksisilin di Puskesmas,  RSIA, rumah sakit swasta dan klinik swasta di Kota Bandung. Hasil: Tingkat rasionalitas penggunaan amoksisilin pada beberapa layanan rawat jalan di fasilitas kesehatan Kota Bandung sebesar 68,26% dari 249 pasien.  Rasionalitas berdasarkan kriteria ketepatan pemberian obat 100%, ketepatan dosis 85,88%, ketepatan durasi 18,92%. Kesimpulan: Potensi resistensi berdasarkan gambaran ketepatan pemberian obat, dosis dan durasi amoksisilin sebesar 31,74%.

Penulis

Sri Setiatjahjati
Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari
Sahnaz Sahnaz
Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari
Rina Rina
Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari
eydina eydina
Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari
Rismayanti Rismayanti
Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Al-Ghifari

Cara Mengutip

POLA PEMBERIAN AMOKSISILIN PADA BEBERAPA MORBIDITAS LAYANAN. (2024). Jurnal Sabdariffarma: Jurnal Ilmiah Farmasi, 11(2), 36-41. https://doi.org/10.53675/jsfar.v11i2.1203

Please find the rights and licenses in Jurnal Sabdariffarma. By submitting the article/manuscript of the article, the author(s) agree with this policy. No specific document sign-off is required.

  1. License

The non-commercial use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution-Share Alike 4.0 International License. 

  1. Author(s)' Warranties

The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).

  1. User Rights

Sabdariffarma's spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, Sabdariffarma permits users to copy, distribute, display, and perform the work for non-commercial purposes only. Users will also need to attribute authors and Sabdariffarma on distributing works in the journal and other media of publications.

  1. Rights of Authors

Authors retain all their rights to the published works, such as (but not limited to) the following rights;

  • Copyright and other proprietary rights relating to the article, such as patent rights,
  • The right to use the substance of the article in own future works, including lectures and books,
  • The right to reproduce the article for own purposes,
  • The right to self-archive the article,
  • The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (Jurnal Sabdariffarma).
  1. Co-Authorship

If the article was jointly prepared by more than one author, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. Sabdariffarma will not be held liable for anything that may arise due to the author(s) internal dispute. Sabdariffarma will only communicate with the corresponding author.

  1. Royalties

Being an open accessed journal and disseminating articles for free under the Creative Commons license term mentioned, author(s) aware that Sabdariffarma entitles the author(s) to no royalties or other fees. 

  1. Miscellaneous

Sabdariffarma will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. Sabdariffarma's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

##plugins.themes.bootstrap3.article.details##

Referensi

Aberg, J.A., Lacy,C.F, Amstrong, L.L, Goldman, M.P, and Lance, L.L.2009. Drug Information Handbook, 17 edition. Lexi-Comp for the American Pharmacists Association.

Avery T., Barber N., dkk. 2012. Investigating the Prevalence and causes of prescribing Errors in General Practice. United Kingdom: Council Regulating Doctors Ensuring Good Medical Practice.

Departemen Kesehatan RI. 2005. Pharmaceutical Care Untuk Penyakit Infeksi Saluran Pernafasan. Jakarta: Direktorat Bina Farmasi Komunitas dan Klinik Direktorat Jendral Bina Kefarmasian dan Alat Kesehatan

Departemen Kesehatan RI. 2009. Kategori Usia. Dalam http://kategori-umurmenurut-Depkes.html. Diakses Pada Tanggal 20 Juni 2016

Departemen Kesehatan RI. 2011. Peraturan Menteri Kementerian Kesehatan Nomor 2406/Menkes/Per/XII/2011 tentang Pedoman Umum Penggunan Antibiotik. Jakarta: Departemen Kesehatan RI.

Sidharti, L, Giok P, Rika L, Tri U S. 2015. Kesesuaian Peresepan Penyakit Faringtis Akut terhadap Standar Pengobatan di Puskesmas Rawat Inap Simpur Bandar Lampung Tahun 2013. J Agromed Unila. Lampung : Unila Pers.

World Health Organization. 2001. WHO World Health Organization Report 2000. Genewa: WHO.

WHO. 2014. Antimicrobial resistance: global report on surveillance 2014. World Health Organization Programmes and Projects. http://www.who.int/drugresistance/documents/surveillancereport/en/ (diakses 28 Januari 2018).

Artikel paling banyak dibaca berdasarkan penulis yang sama